Understanding the impact of combined TB and HIV diagnosis in diverse epidemics


Canada, Canada


10/01/2012 - 03/01/2016


David Dowdy, MD, PhD, ScM

We are developing models to understand the overlap of TB and HIV in three epidemiologically distinct settings (Canada, India, and Uganda), including the potential role of different combined diagnostic strategies, given the different breakdown of populations at high TB risk, high HIV risk, and high combined TB/HIV risk.


APT: Assessing PA-824 for Tuberculosis

A Phase 2 clinical trial of PA-824, an investigational nitroimidazole, as part of multidrug therapy for pulmonary TB; in...

Read More

Understanding the costs and...

We have conducted an empirical costing analysis of facility-based versus community-based treatment for TB in Bangladesh and are...

Read More

Quantitative assessment of the tipping point...

Quantitative methods will be used to study Mtb dynamics to determine the tipping point for macrophage infection, which depends...

Read More

ICOHRTA Training Program (Fogarty)

International Clinical, Operational, and Health Services Research Award (ICOHRTA) training program. A training program that...

Read More